Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis
about
HVPG signature: A prognostic and predictive tool in hepatocellular carcinomaNew advances in hepatocellular carcinomaNoninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond.Prevention of portal hypertension: from variceal development to clinical decompensationSystematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosisPrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesDiagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy.Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort studyInvasive and non-invasive diagnosis of cirrhosis and portal hypertensionWhat are the implications of the spontaneous spleno-renal shunts in liver cirrhosis?Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase.Platelet-related phenotypic patterns in hepatocellular carcinoma patients.Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases.Recent advances in the management of variceal bleedingDiagnostic Imaging of Hepatocellular Carcinoma - A Pictorial Essay.Treatment of portal hypertensionClinical pharmacology of portal hypertension.Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis CNonselective beta-blockers in cirrhotic patients with no or small varices: A meta-analysis.Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection.The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.Elevated levels of endothelin-1 in hepatic venous blood are associated with intrapulmonary vasodilatation in humans.Portal hypertensive gastropathy as a prognostic index in patients with liver cirrhosis.After proper optimization of carvedilol dose, do different child classes of liver disease differ in terms of dose tolerance and response on a chronic basis?Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varicesChallenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint WorkshopPrognostic indicators of survival in patients with compensated and decompensated cirrhosis.Quantitative histological-hemodynamic correlations in cirrhosis.Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt.Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging.Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension.Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis.Hepatic venous pressure gradient: clinical use in chronic liver disease.Cardiovascular changes in cirrhosis: pathogenesis and clinical implications.Indications for portal pressure measurement in chronic liver disease.Potential for statins in the chemoprevention and management of hepatocellular carcinoma.Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside.Natural history of cirrhosis.Assessing portal hypertension in liver diseases.
P2860
Q26738597-7B5C0FBB-7FE0-4647-B371-4ED45947A9A3Q26749329-E72A5981-BFB6-4D4C-B56D-D73A9C420501Q26853160-EE88B77C-4508-4673-B469-D08A67EFEA47Q26865665-D6A27397-9B4B-4C60-A4EB-530FF7749FBFQ27013775-FD7C70D1-4F7B-4E29-9F7B-FBDCA177AE17Q28272678-56422F6C-A4DF-481B-BFE7-FF5973083636Q30355947-3D692570-E35B-4E25-B0B5-B5AAAD65FE1FQ30395363-EBBBAD6B-185E-453C-B092-307082BC1A43Q30439743-BC39252B-CFFA-405D-A19F-D7F1A819831AQ30908529-DF1ED1D9-DBD3-494C-8A65-D338C5C327BFQ33410073-56968B62-FFEE-4803-A02F-3728EE83687CQ33416416-24BB8803-207C-4B30-8C6E-2EB57E8ACE54Q33555680-95A6FB3C-F490-41D3-BEA5-2C2B0E7650A0Q33647530-42648D21-A4FC-41B8-902A-A2950A4821D2Q33668652-8B4FAE64-BE4C-48BB-9693-BDE05BA81006Q34265176-0C19C3EA-22A7-40CB-A06D-BABC579F7128Q34399357-E61E8B6C-C535-4E25-92EB-DA14D7C05AF7Q34671935-2707C221-86C7-4598-B3D1-AC45172999EFQ35169410-5EFEC40E-48A0-44C0-ADB2-C3939100C817Q35237338-1D743D38-50A5-4F8B-A05A-FBA4F56F48ECQ35590977-850510A6-1991-478E-974F-7C5EDC3B772CQ35928746-B190C332-258C-428C-A4BD-A4D1F722F412Q35991529-323FC990-93BB-4F1D-8B3F-F90348A82D36Q36103098-DCB268E2-6D8E-4CF6-A40D-B6B542672493Q36246310-D1BD6AD8-ADF5-410A-ACEB-38AAFF658D46Q36682618-CB33717B-6A37-44FA-BF23-E3DDB24E1EEBQ36987260-E634724D-A670-40F0-9C11-A0E6300B1939Q37019451-4910885B-2D4D-4502-AD64-2A21AEDAEDDAQ37039936-D0C41B8B-019E-4D86-AEB0-EE88E947EA23Q37408313-D9D7E1EA-1DB2-42C0-AA2E-8156890D5DB8Q37441985-507008DD-327E-4906-9622-FEB874930698Q37651909-F6D63EFC-E1AB-4518-97E4-E056F7E64B83Q37676132-6805F5D3-3256-428F-A210-9469ED0EEEB4Q37711328-B3551697-AF80-42D6-955F-2B40DAAC51DFQ37771146-85D75FBF-7F78-49D7-A802-40B100F72AA2Q38027225-2FC3005C-114A-4045-B616-BB078009E046Q38030991-9B0601FC-86AE-42DC-9EBD-0DE6E8B64F17Q38046452-852F947F-18B3-499F-9442-D3191A856BADQ38073661-192F1011-ECE0-483C-8E24-275AD6FCD227Q38077823-62C1E625-03A6-4648-8E16-2166A2EB93CF
P2860
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatic venous pressure gradie ...... ently of severity of cirrhosis
@en
Hepatic venous pressure gradie ...... ntly of severity of cirrhosis.
@nl
type
label
Hepatic venous pressure gradie ...... ently of severity of cirrhosis
@en
Hepatic venous pressure gradie ...... ntly of severity of cirrhosis.
@nl
prefLabel
Hepatic venous pressure gradie ...... ently of severity of cirrhosis
@en
Hepatic venous pressure gradie ...... ntly of severity of cirrhosis.
@nl
P2093
P2860
P1476
Hepatic venous pressure gradie ...... ently of severity of cirrhosis
@en
P2093
Angels Escorsell
Cristina Ripoll
Daniel S Matloff
David Patch
Guadalupe Garcia-Tsao
Jaime Bosch
Juan Carlos Garcia-Pagan
Norman Grace
Portal Hypertension Collaborative Group
Ramon Planas
P2860
P304
P356
10.1016/J.JHEP.2009.01.014
P577
2009-03-05T00:00:00Z